PLoS ONE (Jan 2016)
Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0161779.].